Cancer Medicine Journal Citation Rate 2026
2045-7634
Wiley
GB
Q1 Quartile Open Access Established Impact Verified Publisher
About Cancer Medicine
Cancer Medicine (CM) is a peer-reviewed academic journal covering Cancer Immunotherapy and Biomarkers and Cancer survivorship and care, published by Wiley in GB, catalogued under ISSN 2045-7634. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.12 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $3025 USD.
Cancer Medicine Citation Rate 2026 — In Context
Cancer Medicine has a 2025 2-Year Citation Rate (OpenAlex) of 3.12, placing it in the Q1 quartile within the Cancer Immunotherapy and Biomarkers research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Cancer Medicine makes all articles freely available to readers for an Article Processing Charge of approximately $3025 USD.
Researchers looking to publish in Cancer Medicine should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Medicine against similar journals in the field, use our journal comparison tool.
Submission Tips for Cancer Medicine
- Budget $3025 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer Immunotherapy and Biomarkers, Cancer survivorship and care, Ferroptosis and cancer prognosis. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Medicine Compares
Compared against 41 journals in the same research areas.
| ISSN (Print) | 2045-7634 |
|---|---|
| Publisher | Wiley |
| Country | United Kingdom |
| APC / Cost | $3025 USD |
In-depth profile & metrics
Cancer Medicine is published by Wiley and based in United Kingdom. It publishes open access with an article-processing charge of USD 3025.
In our subject taxonomy, Cancer Medicine is classified under Cancer Immunotherapy and Biomarkers, Cancer survivorship and care, Ferroptosis and cancer prognosis and Global Cancer Incidence and Screening.
Cancer Medicine is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 3.123.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer Medicine
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 3.123 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Cancer Medicine against similar publications in its field:
Related Journals in Your Field
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
Journal of Translational Medicine BioMed Central IF 6.81
-
Cancer Immunology Immunotherapy Springer Science+Business Media IF 4.62
-
Critical Reviews in Oncology/Hematology Elsevier BV IF 4.62
-
BMJ Oncology BMJ IF 4.52
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S2754843627
Get weekly updates for Cancer Immunotherapy and Biomarkers journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.